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Objectives: Early awareness and alert (EAA) activities are increasingly recognized to be an important component of the health technology assessment (HTA) process. Sharing information on methods
used in this discipline is vital to ensure the development of sustainable systems. The objectives of this study is to outline the approach taken to share the different methods that members of the
EuroScan International Network use by producing a methods toolkit; and to provide an overview of the similarities and differences in methods adopted by EAA systems.
Methods: A Delphi technique was used to develop the methods toolkit. Structured questionnaires were used to identify the sources used in the identification of emerging technologies and to determine
the methods used by agencies to carry out EAA activities.
Results: A methods toolkit incorporating guidance on all of the stages described by EuroScan members was produced. The toolkit and an accompanying checklist presents users with different methods
that can be adopted to suit their needs. The comparative analysis demonstrates that different methods are being used by EAA systems dependent on resources available and customer requirements.
Differences in identification, filtration, prioritization, and assessment are apparent along with the role of collaborators in these processes.
Conclusions: The methods used by EAA systems are not homogeneous resulting in a toolkit constructed on the basis of “one size doesn’t fit all.” Methods in this discipline are developing continually to
accommodate changes in health systems and the HTA world. Differences between agencies and the sharing of ideas and experiences enable EAA agencies to adapt to these developments.
Keywords: Early awareness and alert systems, Horizon scanning, Health technology, Identification, Methods toolkit
The identification, filtration, prioritization, and subsequent as-
sessment of significant new and emerging health technologies,
known as early awareness and alert (EAA) activities, contributes
to improved decision making processes, providing timely and
useful information on relevant technologies for their adoption
(or not) in healthcare systems throughout the developed world
(15). The purpose of these activities is to assist in the control and
streamlined adoption and diffusion of new health technologies
within health systems (5). However, new and emerging health
technologies are not a single entity and encompass a wide range
of technologies from pharmaceuticals, devices, diagnostic tests,
and surgical procedures, to programs and settings (8). In addi-
tion, the healthcare systems that adopt these technologies and
the decision making processes for each type of technology are
complex and varied. These make EAA activities multifaceted
tasks that require robust and transparent methods.
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The International InformationNetwork onNew and Emerg-
ing Health Technologies (EuroScan International Network) was
formally established in 1999 following discussions and work-
shops to establish the feasibility, benefits and need for a collabo-
ration that focused on early awareness and alert activities (1;2).
In September 2006, EuroScan held a workshop to consider its
experiences and achievements; and to discuss EuroScan’s future
roles, goals and collaborations (15). Following the workshop
EuroScan members agreed that they would develop a methods
toolkit to summarize the various approaches used in EAA sys-
tems for agencies interested in establishing, or improving an
existing, EAA system. Members also agreed to update both the
work performed by Douw et al. in 2003 (4) on Internet-based
sources used to identify new and emerging health technologies,
and the comparative analysis on the status of and methods used
by member agency systems (17).
OBJECTIVE
We aim to summarize the methods and results of research ac-
tivities that specifically relate to methods used within EAA
systems. Our objectives are to describe the methods used to de-
velop the EuroScan methods toolkit and present the key results,
and to describe the similarities and differences in methods used
by EuroScan member agencies, including the use of Internet
based sources for the identification of new and emerging health
technologies.
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METHODS
EuroScan Methods Toolkit
The approach used to develop the toolkit was based on the
Delphi technique. This technique has been described as a
method for structuring a group communication process so that
the process is effective in allowing a group of individuals, as a
whole, to deal with a complex problem (11).
All members of EuroScan, the “expert panel”, contributed
to the content of the toolkit. A first draft was proposed by one of
the EuroScan member agencies followed by 4 rounds at which
3–4 member agencies were given the opportunity to add to,
or comment on previous versions. After each round the feed-
back was collated and the content of the toolkit edited by the
EuroScan Network Coordinator (SS). Care was taken to include
all feedback and communicate all suggestions whilst maintain-
ing a document that was suitable to pass on to the next round of
recipients. After all agencies had been consulted in the individ-
ual rounds, the document was edited and a summary checklist
developed in the form of questions to be considered by those
seeking to establish or review an EAA system. This was then
sent to the whole panel for further comment and revised follow-
ing feedback. The final document was reviewed by all EuroScan
members in April 2009, before publication in June 2009.
Comparative Analysis of EuroScan Members EAA Systems
A comparison of EuroScan member agency structure, pro-
cesses and outputs was carried out in February 2008, and
updated in early 2009. Member agencies completed a ques-
tionnaire comprising forty-two questions about their EAA
system, including questions on structure and funding, aims
and coverage, customers, partnerships and collaborations,
methods, output, dissemination, related activities, and fu-
ture developments. The questionnaire, sent by email, in-
cluded a combination of open-ended and closed questions
(see Supplementary Table 1, which can be viewed online
at www.journals.cambridge.org/thc2012034, for more details).
Reminders were sent to non-responding agencies.
A supplementary questionnaire listing possible sources
available on the Internet for the identification of different types
of new and emerging health technologies was developed and
sent to all EuroScan members in June 2008. The list was de-
rived using previous research findings in this area (5) and the
researchers’ experience. The questionnaire was presented as a
list of sources grouped by type includingWeb sites ofHTAagen-
cies, EAA systems, health organizations, related organizations,
marketing authorization agencies, news sites, and journals. Re-
spondents were asked to indicate if they used the source to
identify technologies or specific technology types, for example,
devices, diagnostics, drugs, procedures, programs, and settings;
and to say how relevant the source was assigning a value from
1 to 9 (from most to least relevant). A score of 0 was assigned
if the source was not used. Respondents were also given the
opportunity to add new sources. In total, three reminders were
sent to agencies not replying to the initial request(s) to complete
the questionnaire. Once the completed questionnaires were re-
ceived, the median score for each source was calculated and the
sources were ordered according to the number of votes and the
median score they obtained.
RESULTS
EuroScan Methods Toolkit
The toolkit resulting from the consultative process (16) incor-
porated guidance on all of the stages involved in an EAA system
(Figure 1). These stages were not all carried out by all mem-
ber agencies and when they were carried out agencies often
document different approaches.
Twenty-one key questions for those seeking to estab-
lish or review an EAA system were developed (Table 1
and supplementary Table 2, which can be viewed online at
www.journals.cambridge.org/thc2012034). The final toolkit is
available on the EuroScan International Network Web site
(http://www.euroscan.org.uk) and two workshops based on the
structure and content of the toolkit have been delivered to in-
ternational audiences at Health Technology Assessment inter-
national (HTAi) conferences in Dublin 2010 and Rio de Janeiro
2011.
Comparative Analysis
All EuroScan member agencies responded to the initial ques-
tionnaire (n = 20). Of these EAA systems, 90 percent consid-
ered devices and diagnostics, 80 percent procedures, 70 percent
pharmaceuticals, 60 percent programs, and 50 percent health
care settings. All but one EAAS considered all disease areas
(95 percent). The system that had restricted coverage specifi-
cally identified advances in the oncology field only.
Identification. All agencies had an identification stage in the EAA
system, but the amount of scanning of sources carried out
by agencies to identify new and emerging technologies var-
ied along with the type of sources. Eleven (55 percent) agen-
cies used primary sources available on the Internet. Two
(10 percent) agencies obtained information by liaising with de-
velopers/manufacturers of the technologies. Fifteen agencies
(75 percent) either relied on or supplemented the primary scan-
ning sources with a more reactive approach where technologies
are suggested to them via a Web-based form, input from expert
groups or an open call is made for suggestions.
Completed supplementary questionnaires on Internet-based
identification sources were received from 13 of the 15
EuroScan member agencies. Identification sources that ob-
tained low median scores (a low score indicated a rele-
vant source), for each technology type (devices, diagnostics,
drugs, procedures, programs, settings) are shown in Table 2
and Supplementary Table 3, which can be viewed online at
www.journals.cambridge.org/thc2012034. Of the original list
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Filtration
Prioritisation
Assessment
Horizon
Scanning/Identification 
Dissemination
Peer review
Updating
information
Identify your market 
customers 
Determine your time 
horizon 
Peer review 
Does not meet 
initial criteria 
Meets initial criteria 
Figure 1. Stages involved in early awareness and alert systems.
of sixty-two identification sources provided in the question-
naire, twenty-two were scored as highly relevant or relevant
sources and included in the tables. Some sources are used for
the identification of all types of technologies, for example, med-
ical journals (BMJ, Lancet or JAMA); scientific societies like
American Cancer Society or Internet alert facilities such as
Medscape, whereas others are used to identify specific technol-
ogy types, for example, European Medicines Agency (EMA)
for the identification of new drugs. The EuroScan database of
new and emerging technologies was regarded as highly rele-
vant for the identification of all types of technologies and was
used as a source of identification by most respondents. This was
expected as the technologies on the database are all emerging
or new technologies that have been prioritized by other EAA
systems.
Filtration. All agencies filtered the technologies they identify, to
reduce numbers of health technologies to investigate and assess
to a manageable size; with 18 saying they had a formal filtration
process. Filtration wasmainly carried out in-house (60 percent),
by an expert scientific board (25 percent), by the policy-making
or other customer (15 percent) and/or by individual experts
(10 percent). Some agencies have explicit criteria based on
methodological documents (3;13;14).
Prioritization. Most agencies used prioritization criteria (90 per-
cent). Commonly used criteria were: patient numbers/burden of
disease, potential clinical benefit, possible economic impact and
anticipated speed of adoption (both appropriate and inappropri-
ate). Other criteria considered to a lesser extent were level of
available evidence, existence of alternative technologies, safety
profile of the technology; and social, ethical and legal aspects.
Agencies also stated national, regional and local priorities as
having an influence on the prioritization of technologies for
further consideration.
Assessment and Dissemination. Agencies produced a range of out-
puts with different levels of impact prediction and assessment
(Table 3). The extent to which technologies were assessed also
varieswith the timeframe covered,with those agencies consider-
ing technologies further away from launch having less evidence
to include in their reports. Respondents generated a variety of
report types - short (1–4 pages), long (4–10 pages), comprehen-
sive (>10 pages) and newsletters. These were disseminated by
e-mail (70 percent), Web sites (50 percent), paper (30 percent),
andmedical journals (5 percent). Two agencies (10 percent) pro-
duced reports for internal use only which are not disseminated
externally.
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Table 1. Checklist to Establish an EAAS
Stage 1. Identify your market
1. What is the purpose of your early awareness and alert system (EAAS)?
2. Who do you intend to inform?
3. What does your customer expect from you (and what not)?
4. What type of information is needed?
5. What type of documents (the depth, the length. . . .)
6. What is the scope of your EAAS?
Stage 2. Determine your time horizon
7. When does your customer want information? (it could be more than one)
8. What is the expected time-frame for the type of technology you are
considering to be introduced in the health care system?
Stage 3. Identification Sources
9. Which are the sources your system is going to seek for information?
Stage 4. Filtration. Choose some or add others.
10. Define your filtration criteria
Stage 5. Prioritisation (define your prioritisation criteria). Choose some or add others
11. Define your filtration criteria
Stage 6. Assessment
12. Type of assessment you will use
Stage 7. Peer review
13. Peer review
Stage 8. Dissemination
14. Who will do the dissemination process?
15. When are you thinking of disseminating information?
16. Which are the support media you are considering?
17. Which is going to be the dissemination strategy? (please state)
Stage 9. Updating information
18. In which cases are you going to update information?
19. Which are the sources you are planning to search for updating?
20. When are you planning to update information?
21. Are you going to do a reassessment of the technology?
Collaboration. In carrying out their EAA activities agencies worked
with clinical or scientific individuals (90 percent), existing ex-
pert groups (70 percent) or specially convened expert groups
(50 percent). Forty-five percent of respondents contacted com-
mercial companies, developers or sponsors in their work,mainly
for identification of technologies. Some agencies invited com-
mercial companies and clinicians to comment on the final as-
sessments as part of the review process.
DISCUSSION
Both the development of a methods toolkit and the comparative
analysis of EuroScan member agencies indicate that methods
used by existing EAA systems are not homogeneous. Agen-
cies all use methods that involve some form of identification,
filtration and/or prioritization, and assessment but these differ
depending on customer requirements and desired outcomes, re-
sources available and the time horizon being considered (9).
The EuroScan methods toolkit has brought all the ap-
proaches to EAA activity together in one document for the
first time. The collaborative approach to the development of the
toolkit resulted in an end product covering all aspects of EAA
processes as well as presenting key questions and options for
consideration by anyone developing or modifying an EAA sys-
tem. The Agency for Healthcare Research and Quality (AHRQ)
Healthcare Horizon Scanning System has recently published an
Horizon Scanning Protocol and Operation Manual that out-
lines the basic protocol and decision processes that are being
followed. It covers scanning to identify leads for new interven-
tions, selection of topics for in-depth information searches, and
identification of interventions that could have the greatest po-
tential impact in each priority area (6). The main merit of the
EuroScan toolkit as a starting point in comparison with this and
other individual protocols of EuroScan member agencies is that
it includes different approaches that can be adopted to lead to a
context tailored protocol.
The usage of a Delphi technique to develop a collabora-
tive document from a heterogeneous group is not unique to
EuroScan, consensus methods have been used in other method-
ological guidelines or toolkits in HTA (12). The modified
Delphi approach proved to be successful and enabled a toolkit to
be constructed that represented the views, methods and contexts
of all member agencies. This is an advantage over commentaries
on methods provided by a single agency. The toolkit is not pre-
sented as a directive instruction manual but allows the reader
to consider several methods and adopt the approach that suits
their needs.
The updated comparative analysis of methods confirmed
that agencies do follow the principle EAA steps outlined in
the toolkit and shown in Figure 1 but that their approach to
the steps may be different. It could be said that the similar-
ities illustrate a shared understanding of EAA activities that
has developed though the collaborative efforts of EuroScan.
However, the variations between systems are inevitable in an
international collaboration where health care systems and ser-
vices operate differently and the end products feed a diverse
group of customers with varying needs.
The supplementary questionnaire on Internet-based iden-
tification sources highlights a resource intense process where
agencies differ in their approach. Although systems mainly use
the Internet as an information source to identify new technolo-
gies, the evidence suggests that their use varies and is not homo-
geneous, despite access to sources, on thewhole, being available
to all. In fact, previously published research points to the exis-
tence of a large number of potentially useful sites and that their
use may be based on local preferences by information special-
ists. This may be critical to the outcome of the identification
process (5).
It is also clear that identification sources are not static,
new sources are introduced all the time each varying in their
coverage, relevance, quality, cost, frequency and ease of use.
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Table 2. Sources for the Identification of New and Emerging Technologies (1 = Most Relevant, 9 = Least Relevant)
Devices
Type of source Source Votes Total score Median score
Related organizations ECRI Institute 9 27 2
News sites Medscape 7 21 3
Marketing Authorization Agencies U.S. Food and Drug administration (FDA) 10 30 2
Journals British Medical Journal 11 30 3
JAMA 11 31 3
Lancet 10 36 4
HTA Organizations EuroScan 10 17 1
Canadian Agency for Drugs and Technologies in Health 10 20 2
Diagnostics
Early Assessment & Alert Systems Australia and New Zealand Horizon Scanning Network 8 20 2
HTA Organizations EuroScan 11 21 1
Canadian Agency for Drugs and Technologies in Health 11 23 2
Journals British Medical Journal 12 38 3
JAMA 11 39 3
Lancet 9 32 3
Marketing Authorization Agencies U.S. Food and Drug administration (FDA) 10 30 2
News sites Medscape 8 24 3
Related organizations ECRI Institute 9 26 2
Drugs
HTA Organizations EuroScan 9 23 1
Canadian Agency for Drugs and Technologies in Health 9 37 3
Journals British Medical Journal 9 30 3
JAMA 9 30 3
Marketing Authorization Agencies U.S. Food and Drug administration (FDA) 10 29 2
EMA 12 35 2
Procedures
HTA Organizations Canadian Agency for Drugs and Technologies in Health 11 35 3
EuroScan 10 20 2
National Institute for Health & Clinical Excellence (NICE) 9 26 1
The Cochrane Collaboration 8 25 2
National Horizon Scanning centre 7 18 1
Marketing Authorization Agencies U.S. Food and Drug administration (FDA) 9 38 3
News sites Medscape 7 24 3
Related organizations ECRI Institute 8 26 2
Programs
Early Assessment & Alert Systems Australia and New Zealand Horizon Scanning Network 6 16 2
HTA Organizations Canadian Agency for Drugs and Technologies in Health 9 40 3
National Institute for Health & Clinical Excellence (NICE) 8 29 2
EuroScan 8 24 2
The Cochrane Collaboration 8 38 5
Centre for Reviews & Dissemination (CRD) 6 19 2
JAMA 9 39 3
News sites Medscape 6 23 3
305 INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 28:3, 2012
Gutierrez-Ibarluzea et al.
Table 3. Content of EAA Reports Relating to Impact Prediction
and Assessment
Main output includes information on: n (%)
Potential for significant health service impact 17 (85)
Level of evidence for safety and efficacy 18 (90)
Assessment of clinical effectiveness 15 (75)
Assessment of cost effectiveness 9 (45)
Potential for other impacts, e.g., legal, social, ethical 4 (20)
Agencies use what provides them with the information most
relevant to their needs, resources and the context in which they
and their decision makers operate. Other research has looked
at how to assess the value of identification sources for hori-
zon scanning (18), using generic databases such as Medline for
identification (19), and sources for the identification of innova-
tive public health interventions (7). The value of these efforts
and their results should be considered by any agency under-
taking EAA activities. EAA systems’ identification, filtration
and prioritization methods are also potentially transferable to
other areas in health service decision making. This may not
only be related to new and emerging technologies but could be
of value when exploring or identifying obsolete or low added
value health technologies (10).
Although heterogeneity amongst a group of individuals and
agencies working together can cause difficulties, one of the
strengths of collaboration is that the different methods, experi-
ences and skills of individual members can be shared and en-
hance the knowledge and practices of other members. Through
this research EuroScan members have embraced these differ-
ences in approach to EAA work and have developed a strong
shared understanding of EAA systems and activities.
The EuroScan International network increased its mem-
bership from 12 in 2006 to 20 in 2010, which has, not only
improved its capability to face more complex activities and
strategies, but has enriched the methods used and the experi-
ences shared. The weakness of the research carried out is that
it does not consider other agencies and systems who are not
members of EuroScan and who may operate in a very different
way. Future work in EuroScan could concentrate on developing
a consistent approach to the identification of new and emerg-
ing health technologies for each technology type. This could be
supplemented by relevant local sources and a more proactive
collaboration with international and local producers and local
users of health technologies.
CONCLUSION
Methods used in EAA systems continue to develop with the
emergence of innovative technologies such as genomics and
regenerative medicines, new pressures on health systems, and
changes in the decision making processes that EAA systems
feed. Differences between agencies in approaches and methods
with the sharing of ideas and experiences,will continue to enrich
these developments and ensure that decision making processes
in healthcare systems continue to be supported.
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